Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SuloPrima: Sulodexide in Chronic Primary Venous Disease
NCT05005052Phase 3Unknown
- Start
- Nov 2021
- Primary completion
- Dec 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulodexide in chronic venous disease (CVD). Status: unknown.
02
Drugs
sulodexide
03
Conditions
chronic venous disease (CVD)
Beyond the preview
Go deeper on NCT05005052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05005052.